NASDAQ:XMTR News 17 December 2025

Xometry stock slides about 3.5% in year-end trade; what XMTR investors are watching next

Xometry shares dropped 3.5% to $60.94 in midday trading Wednesday, outpacing broader market declines on thin year-end volume. No new company filings or announcements appeared on the SEC’s EDGAR feed. The move followed a choppy stretch for the stock and came as investors repositioned portfolios ahead of 2026.

31 December 2025

NASDAQ:SSYS·NASDAQ:XMTR·NYSE:PRLB·Stock Market

Xometry XMTR Stock Rallies on December 17 2025 as Earnings Momentum and Analyst Forecasts Stay in Focus

Xometry, Inc. shares (NASDAQ: XMTR) were among the notable U.S. gainers on Wednesday, December 17, 2025, extending a strong run that has increasingly put the AI-powered manufacturing marketplace back on traders’ radar. As of the latest available quote, XMTR traded around $64.66, up about 6% on the day versus the prior close of $60.91. That upside stood out against a softer broader tape at the time, with major U.S. benchmarks showing declines while XMTR appeared on “top gainers” lists—an early signal that the day’s move was being driven more by company-specific positioning and continued “earnings digestion” than by index-level tailwinds.

17 December 2025

Earnings Reports·NASDAQ:XMTR·Stock Market

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

7 February 2026

Philip Morris International closed at $182.81, up 0.45%, after raising its 2026 profit outlook on stronger nicotine pouch sales. Fourth-quarter adjusted EPS rose to $1.70, with net revenue up 6.8% to $10.36 billion. CEO Jacek Olczak said updated Zyn products are pending regulatory approval. The next dividend declaration is set for March 5, 2026.

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

7 February 2026

Novartis shares closed up 0.6% in Zurich at 119.96 francs Friday, with U.S. ADRs gaining 1.5%. The company broke ground on a new San Diego research center and reported a positive draft reimbursement recommendation for Kisqali in Canada. Investors are watching for the March 6 annual meeting and March 10 ex-dividend date tied to a proposed 3.70-franc payout.

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026

AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

7 February 2026

Wells Fargo shares rose 2.63% to $93.97 Friday as U.S. stocks rebounded. The stock traded ex-dividend for a $0.45 payout due March 1. Investors await delayed U.S. jobs and inflation data next week and a scheduled CFO appearance at a bank conference.

NASDAQ:XMTR News 17 December 2025 - 31 December 2025

Xometry stock slides about 3.5% in year-end trade; what XMTR investors are watching next

Xometry XMTR Stock Rallies on December 17 2025 as Earnings Momentum and Analyst Forecasts Stay in Focus

Stock Market Today

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

AstraZeneca stock price: What could move AZN next week as earnings loom

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week